Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.
Am. J. Hypertens., Sep;12(9 Pt 1):906-14 (1999)
Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia.
Int Urol Nephrol., 33(3):407-12 (2001)
Is it time to move to multidrug combinations?
Am. J. Hypertens., Nov;16(11 Pt 2):36S-40S (2003)
Clinical pharmacology of antihypertensive therapy.
Semin. Nephrol., Jul;25(4):215-26 (2005)
Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Clin Ther., Jan;29(1):61-73 (2007)
Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
Am. J. Hypertens., Jan;20(1):11-20 (2007)
Direct renin inhibition: focus on aliskiren.
J Manag Care Pharm., Oct;13(8 Suppl B):21-33 (2007)
The role of baseline blood pressure in guiding treatment choice: a secondary analysis of the use of valsartan/hydrochlorothiazide as initial therapy in hypertensive adults in a randomized, double-blind, placebo-controlled trial.
Clin Drug Investig., 29(12):791-802 (2009)
Clinical role of direct renin inhibition in hypertension.
Am J Ther., May;19(3):204-10 (2012)
Role of the sympathetic nervous system in hypertension and benign prostatic hyperplasia.
Br J Clin Pract Suppl., May;74:13-7 (1994)
Effects of doxazosin on coronary heart disease risk factors in the hypertensive patient.
Br J Clin Pract Suppl., May;74:8-12 (1994)
Effects of doxazosin on serum lipids: a review of the clinical data and molecular basis for altered lipid metabolism.
Am. Heart J., Jan;121(1 Pt 2):251-9; discussion 259-60 (1991)
Localization of ectopic pheochromocytomas by magnetic resonance imaging.
Am. J. Med., Oct;83(4):770-2 (1987)
Clinical experience and rationale for angiotensin-converting enzyme inhibition with lisinopril as the initial treatment for hypertension in older patients.
Am. J. Med., Sep;85(3B):19-24 (1988)
Spectrum of dysautonomia in mitral valvular prolapse.
Am. J. Med., Mar;86(3):267-74 (1989)
Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronate.
J. Bone Miner. Res., Apr;4(2):143-8 (1989)
Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension.
Am. J. Hypertens., Apr;11(4 Pt 1):462-70 (1998)
Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study.
J Clin Pharmacol., May;39(5):471-9 (1999)
Dose-response efficacy of valsartan, a new angiotensin II receptor blocker.
J Hum Hypertens., Apr;13(4):275-81 (1999)
The editor's roundtable: concurrent hypertension and dyslipidemia.
Am. J. Cardiol., Jan;99(1):134-44 (2007)